Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Adams

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Genomics|October 16, 2014
Experimental microbial evolution: history and conceptual underpinningsJulian Adams, Frank Rosenzweig
Cancer Investigation|June 18, 2004
Development of the proteasome inhibitor Velcade (Bortezomib)Julian Adams, Michael Kauffman
Evolution; International Journal of Organic Evolution|June 2, 2017
COEVOLUTION IN BACTERIAL-PLASMID POPULATIONSRajiv I Modi, Julian Adams
FEMS Yeast Research|January 22, 2004
Ty1 insertions in intergenic regions of the genome of Saccharomyces cerevisiae transcribed by RNA polymerase III have no detectable selective effectVictoria M Blanc, Julian Adams
Genetics|December 12, 2003
Evolution in Saccharomyces cerevisiae: identification of mutations increasing fitness in laboratory populationsVictoria M Blanc, Julian Adams
Plos Genetics|June 27, 2014
Ex uno plures: clonal reinforcement drives evolution of a simple microbial communityMargie Kinnersley, Jared Wenger, Evgueny Kroll, et al.
The Journal of Biological Chemistry|February 28, 2002
Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretionZita Balklava, Elisabetta Verderio, Russell Collighan, et al.
Journal of Virology|March 1, 2003
Retroviruses have differing requirements for proteasome function in the budding processDavid E Ott, Lori V Coren, Raymond C Sowder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancerJiabin An, Yi-Ping Sun, Julian Adams, et al.
Methods in Molecular Medicine|April 25, 2003
Assays for proteasome inhibitionPeter J Elliott, Teresa A Soucy, Christine S Pien, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Genomics|October 16, 2014
Experimental microbial evolution: history and conceptual underpinningsJulian Adams, Frank Rosenzweig
Cancer Investigation|June 18, 2004
Development of the proteasome inhibitor Velcade (Bortezomib)Julian Adams, Michael Kauffman
Evolution; International Journal of Organic Evolution|June 2, 2017
COEVOLUTION IN BACTERIAL-PLASMID POPULATIONSRajiv I Modi, Julian Adams
FEMS Yeast Research|January 22, 2004
Ty1 insertions in intergenic regions of the genome of Saccharomyces cerevisiae transcribed by RNA polymerase III have no detectable selective effectVictoria M Blanc, Julian Adams
Genetics|December 12, 2003
Evolution in Saccharomyces cerevisiae: identification of mutations increasing fitness in laboratory populationsVictoria M Blanc, Julian Adams
Plos Genetics|June 27, 2014
Ex uno plures: clonal reinforcement drives evolution of a simple microbial communityMargie Kinnersley, Jared Wenger, Evgueny Kroll, et al.
The Journal of Biological Chemistry|February 28, 2002
Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretionZita Balklava, Elisabetta Verderio, Russell Collighan, et al.
Journal of Virology|March 1, 2003
Retroviruses have differing requirements for proteasome function in the budding processDavid E Ott, Lori V Coren, Raymond C Sowder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancerJiabin An, Yi-Ping Sun, Julian Adams, et al.
Methods in Molecular Medicine|April 25, 2003
Assays for proteasome inhibitionPeter J Elliott, Teresa A Soucy, Christine S Pien, et al.
Pageof 7